Currently out of the existing stock ratings of James Vane-Tempest, 9 are a BUY (45%), 8 are a HOLD (40%), 3 are a SELL (15%).

James Vane-Tempest

Work Performance Price Targets & Ratings Chart

Analyst James Vane-Tempest, currently employed at JEFFERIES, carries an average stock price target met ratio of 22.5% that have a potential upside of 39.74% achieved within 99 days.

James Vane-Tempest’s has documented 39 price targets and ratings displayed on 5 stocks. The coverage is on Healthcare, Energy sectors.

Most recent stock forecast was given on FMS, Fresenius Medical Care at 08-Aug-2024.

Wall Street Analyst James Vane-Tempest

Analyst best performing recommendations are on AP (AMPCO-PITTSBURGH).
The best stock recommendation documented was for PHG (KONINKLIJKE PHILIPS NV ADR) at 10/18/2022. The price target of $11.16 was fulfilled within 16 days with a profit of $1.3 (10.43%) receiving and performance score of 6.52.

Average potential price target upside

AP Ampco-Pittsburgh CVS CVS Health Corp FMS Fresenius Medical Care PHG Koninklijke Philips NV ADR SM SM Energy Co

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 06-Feb-2020

$7

$-2.35 (-25.13%)

$12

2 years 3 months 25 days ago
(11-Jun-2024)

6/6 (100%)

$5.91 (542.20%)

992

Buy Since 05-Jul-2021

$5

$-3.14 (-38.57%)

$7

2 years 8 months 5 days ago
(01-Feb-2024)

2/2 (100%)

$2.46 (96.85%)

1189

Buy Since 05-Jan-2022

$5

$-1.86 (-27.11%)

3 years 6 months 1 days ago
(05-Apr-2023)

1/2 (50%)

$2.3 (85.19%)

999

Buy Since 29-Apr-2020

$1

3 years 6 months 29 days ago
(07-Mar-2023)

3/3 (100%)

$-3.03 (-75.19%)

332

Buy Since 20-Jul-2022

$5

$-3.14 (-38.57%)

$10

3 years 10 months 28 days ago
(08-Nov-2022)

1/2 (50%)

$1.55 (44.93%)

1147

Show more analysts

Please expand the browser size to see the chart

What Year was the first public recommendation made by James Vane-Tempest?

On 2019
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?